Clinical Trial Update: Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating sunitinib in patients with metastatic kidney cancer, including brain metastases. The update notes completion but does not p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Renal Cell Carcinoma

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Kidney Cancer, Metastatic Cancer | Phase 2 | Status: COMPLETED